Startup

Regenosca

Description

Regenosca is a medical technology startup focused on developing and commercializing a new generation of biomaterials for soft tissue repair. Their innovative implant technology platform offers a less invasive alternative to using a patient's own tissue grafts, providing off-the-shelf, ready-to-use solutions that act as a bridge for tissue reconstruction. The implants are 100% natural, customizable to fit clinical needs, and promote cell migration from surrounding tissue. Regenosca's first indication is urethral reconstruction, addressing conditions like urethral stricture and hypospadias. The startup has successfully validated the proof-of-concept of their implant technology with first human data, showcasing promising results in reducing operation time and improving surgical outcomes.

About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.